课题基金 / 基金详情

Role of the SasAB locus in S. aureus Biofilms

Role of the SasAB locus in S. aureus Biofilms
SasAB 基因座在金黄色葡萄球菌生物膜中的作用
批准号:
6834009
负责人:
ROBERT M SHANKS
金额:
$4.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2005-07-31

项目摘要

项目成果

ROBERT M SHANKS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Biofilms are communities of bacteria that adhere to surfaces, and represent the physiological state in which most bacteria exist. Bacteria in biofilms behave differently than do bacterial cells suspended in culture medium (planktonic cells). Notably cells in biofilms are much more resistant to antibiotics and other biocides. Biofilms profoundly affect mankind. There are many links between biofilms and disease; it is estimated that more than half of all human bacterial infections involve biofilms. Biofilms growing on tissue, implants and medical tubing can be highly problematic and extremely difficult to treat. Staphylococcus aureus is major agent of nosocomial infections and capable of forming robust biofilms on biotic and abiotic surfaces. Yet, we know only a limited number of factors that contribute to S. aureus biofilm formation. Identified factors may become important vaccine and drug targets. Therefore, it will be important to elucidate the genetic factors involved in S. aureus biofilm formation. This proposal describes biochemical and genetic experiments designed to characterize novel factors that contribute to S. aureus biofilm formation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/ndt/gfl170
发表时间: 2006-08
期刊: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
影响因子: --
作者: [R. Shanks;J. Sargent;R. M. Martínez;Martha L. Graber;G. O’Toole]
通讯作者: R. Shanks;J. Sargent;R. M. Martínez;Martha L. Graber;G. O’Toole
Rise of lasR mutant Pseudomonas aeruginosa keratitis
Rise of lasR mutant Pseudomonas aeruginosa keratitis
Rise of lasR mutant Pseudomonas aeruginosa keratitis
NOT-NS-20-030: Use of anchored biologics to treat vesicant induced neovascularization